Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade

類似資料

• Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy
  著者:: Monjazeb, Arta M, 等
  出版事項: (2015)
• Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Anti-tumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies
  著者:: Monjazeb, Arta M., 等
  出版事項: (2016)
• Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
  著者:: Monjazeb, Arta Monir, 等
  出版事項: (2013)
• CpG oligodeoxynucleotides as immunotherapy in cancer
  著者:: Jahrsdörfer, Bernd, 等
  出版事項: (2008)
• Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms
  著者:: Loftis, Jennifer M.
  出版事項: (2013)